Liquid Biopsies – our new study reveals trends, R&D progress, and predicted revenues
Where is the liquid biopsy market heading? If you are involved in this sector you must read this brand-new report. Visiongain’s report shows you the potential revenues streams to 2028, assessing data, trends, opportunities and business prospects there.
Discover How to Stay Ahead
Our 156-page report provides 144 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing liquid biopsy market. See how to exploit the opportunities.
Forecasts to 2028 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2028, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, you find revenue forecasts for 5 different segmentations of the market, including forecasts for 3 product types, 3 sample types, 3 biomarker types, 6 applications and 4 end users:
• Liquid biopsy Market Forecasts to 2028, By Product Type
• Instruments
• Kits & Reagents
• Services
• Liquid biopsy Market Forecasts to 2028, By Sample Type
• Blood
• Urine
• Other
• Liquid biopsy Technologies Market Forecasts to 2028, By Biomarker Type
• CTC
• ctDNA
• Exosomes
• Liquid biopsy Technologies Market Forecasts to 2028, By Application
• Breast Cancer
• Colorectal Cancer
• Liver Cancer
• Lung Cancer
• Prostate Cancer
• Other Cancers
• Liquid biopsy Technologies Market Forecasts to 2028, By End User
• Hospitals
• Academic Institutes
• Diagnostic Laboratories
• Cancer Research Centres
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts 5 leading regional markets and 19 leading national markets:
• North America
• US
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• APAC
• Japan
• China
• India
• South Korea
• Singapore
• Australia & New Zealand
• Rest of APAC
• Latin America
• Brazil
• Argentina
• Rest of Latin America
• MEA
• GCC
• South Africa
• Rest of MEA
There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2028. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.
Leading companies and the potential for market growth
Overall world revenue for liquid biopsy will surpass $600bn in 2018, our work calculates. We predict strong revenue growth through to 2028.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Liquid biopsy Technologies Market report helps you
In summary, our 156-page report provides you with the following knowledge:
• Revenue forecasts to 2028 for the world liquid biopsy market and 5 different segmentations, with 3 product types, 3 sample types, 3 biomarker types, 6 applications and 4 end-user types – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2028 for the leading 5 regional and 19 national markets – North America (US, Canada), Latin America (Brazil, Argentina, Rest of Latin America), Europe (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), APAC (Japan, China, India, South Korea, Singapore, Australia & New Zealand and Rest of APAC), LAMEA (GCC, South Africa and Rest of MEA)
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the <enter sector> market and leading companies. You find data, trends and predictions.
Get our report today Global Liquid Biopsy Market Forecast 2018-2028: Analysis of the Liquid Biopsy Market by Product, Biomarker, Sample, Cancer and End User, Instruments, Kits and Reagents, Services, Blood Sample, Urine Sample, Circulating Tumour Cell (CTC), Circulating Tumour DNA (ctDNA), Exosomes, Breast Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Prostate Cancer, Hospitals, Diagnostic Laboratories, Academic Institutions and Cancer Research Centres. Avoid missing out.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Global Liquid Biopsy Market Overview
1.2 Liquid Biopsy Market Definition & Scope
1.3 Overview of Findings
1.4 Structure of the Report
1.5 Key Questions Answered by This Analytical Report
1.6 How This Report Delivers
1.7 Who is This Report For?
1.8 Methodology
1.8.1 Primary Research
1.8.2 Secondary Research
1.8.3 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Liquid Biopsy Market Overview
2.1 History of Liquid Biopsies
2.2 Advantages of Liquid Biopsies
2.3 Trends in Liquid Biopsy Market
2.3.1 Companies Increasingly Focusing on Developing Biomarkers Detection Kits
2.3.2 Emergence of Oncogenic Mutations Detection Platforms
2.3.3 Rising Demand for Minimally Invasive Cancer Biomarkers Detecting Procedures
2.4 Market Dynamics
2.4.1 Drivers
2.4.1.1 Rise in global incidence of cancer
2.4.1.2 Increasing Rate of Aging Population
2.4.1.3 Rise in demand for safe and minimally invasive procedures
2.4.1.4 Advantages of liquid biopsy
2.4.2 Restraints
2.4.2.1 Disparity in reimbursements
2.4.2.2 Strict regulatory environment
2.4.3 Opportunities:
2.4.3.1 Increasing involvement of global market players through collaborations/agreements
2.4.3.2 Progress in the development of liquid biopsy tests
2.5 Global Liquid Biopsy Market: Revenue Forecast, 2017-2028
3. Global Liquid Biopsy Market, by Product Type 2018-2028
3.1 Global Liquid Biopsy Market, By Product Type, Revenue Forecast, 2018-2028
3.2 Instruments Segment
3.2.1 Global Liquid Biopsy Market, Instruments Segment Revenue Forecast, 2018-2028
3.3 Kits & Reagents Segment
3.3.1 Global Liquid Biopsy Market, Kits & Reagents Segment Revenue Forecast, 2018-2028
3.4 Services Segment
3.4.1 Global Liquid Biopsy Market, Services Segment Revenue Forecast, 2018-2028
3.5 Market Share Analysis, by Product Type
4. Global Liquid Biopsy Market, by Sample Type 2018-2028
4.1 Global Liquid Biopsy Market, By Sample Type, Revenue Forecast, 2018-2028
4.2 Global Liquid Biopsy Market, Blood Sample Segment Revenue Forecast, 2018-2028
4.3 Global Liquid Biopsy Market, Urine Sample Segment Revenue Forecast, 2018-2028
4.4 Global Liquid Biopsy Market, Other Samples Revenue Forecast, 2018-2028
4.5 Market Share Analysis, by Sample Type
5. Global Liquid Biopsy Market, by Biomarker Type 2018-2028
5.1 Global Liquid Biopsy Market, By Biomarker Type, Revenue Forecast, 2018-2028
5.2 Global Liquid Biopsy Market, Circulating Tumour Cell (CTC) Segment Revenue Forecast, 2018-2028
5.3 Global Liquid Biopsy Market, Circulating Tumour DNA (ctDNA) Segment Revenue Forecast, 2018-2028
5.4 Global Liquid Biopsy Market, Exosomes Segment Revenue Forecast, 2018-2028
5.5 Global Liquid Biopsy Market, Other Biomarkers Segment Revenue Forecast, 2018-2028
5.6 Market Share Analysis, by Biomarker Type
6. Global Liquid Biopsy Market, by Cancer Type 2018-2028
6.1 Global Liquid Biopsy Market, By Cancer Type, Revenue Forecast, 2018-2028
6.2 Global Liquid Biopsy Market, Breast Cancer Segment Revenue Forecast, 2018-2028
6.3 Global Liquid Biopsy Market, Colorectal Cancer Segment Revenue Forecast, 2018-2028
6.4 Global Liquid Biopsy Market, Liver Cancer Segment Revenue Forecast, 2018-2028
6.5 Global Liquid Biopsy Market, Lung Cancer Segment Revenue Forecast, 2018-2028
6.6 Global Liquid Biopsy Market, Prostate Cancer Segment Revenue Forecast, 2018-2028
6.7 Global Liquid Biopsy Market, Other Cancers Segment Revenue Forecast, 2018-2028
6.8 Market Share Analysis, by Cancer Type
7. Global Liquid Biopsy Market, by End User 2018-2028
7.1 Global Liquid Biopsy Market, By End User, Revenue Forecast, 2018-2028
7.2 Global Liquid Biopsy Market, Hospitals Segment Revenue Forecast, 2018-2028
7.3 Global Liquid Biopsy Market, Diagnostic Laboratories Segment Revenue Forecast, 2018-2028
7.4 Global Liquid Biopsy Market, Academic Institutions Segment Revenue Forecast, 2018-2028
7.5 Global Liquid Biopsy Market, Cancer Research Centres Segment Revenue Forecast, 2018-2028
7.6 Market Share Analysis, by End User
8. Global Liquid Biopsy Market, by Leading Nationals 2018-2028
8.1 Global Liquid Biopsy Market, By Leading Nationals, Revenue Forecast, 2018-2028
8.2 North America
8.2.1 North America Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.2.2 North America Liquid Biopsy Market, Revenue Forecast, By Country, 2018-2028
8.2.3 US Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.2.4 Canada Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.2.5 Mexico Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.3 Europe
8.3.1 Europe Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.3.2 Europe Liquid Biopsy Market, Revenue Forecast, By Country, 2018-2028
8.3.3 Germany Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.3.4 France Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.3.5 United Kingdom Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.3.6 United Kingdom Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.3.7 Italy Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.3.8 Spain Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.3.9 Russia Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.4 Asia-Pacific
8.4.1 Asia-Pacific Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.4.2 Asia-Pacific Liquid Biopsy Market, Revenue Forecast, By Country, 2018-2028
8.4.3 Japan Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.4.4 China Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.4.5 Australia Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.4.6 South Korea Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.4.7 India Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.5 LAMEA
8.5.1 LAMEA Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.5.2 LAMEA Liquid Biopsy Market, Revenue Forecast, By Country, 2018-2028
8.5.3 Brazil Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.5.4 Turkey Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.5.5 Venezuela Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.5.6 Saudi Arabia Liquid Biopsy Market, Revenue Forecast, 2018-2028
8.5.7 Republic of South Africa Liquid Biopsy Market, Revenue Forecast, 2018-2028
9. Leading Companies in Liquid Biopsy Market
9.1 Menarini Silicon Biosystems, Inc.
9.1.1 Overview
9.1.2 Technology
9.1.3 Products
9.1.4 Recent Strategic Developments
9.2 MDxHealth SA
9.2.1 Overview
9.2.2 Financials
9.2.3 Products
9.2.4 Recent Strategic Developments
9.3 Biocept, Inc.
9.3.1 Overview
9.3.2 Financials
9.3.3 Products
9.3.4 Recent Strategic Developments
9.4 Trovagene, Inc.
9.4.1 Overview
9.4.2 Technology
9.4.3 Financials
9.4.4 Products
9.4.5 Recent Strategic Developments
9.5 Sysmex Inostics GmbH (A Subsidiary of Sysmex Corporation)
9.5.1 Overview
9.5.2 Technology
9.5.3 Products
9.5.4 Financials
9.5.5 Recent Developments
9.6 F. Hoffmann-La Roche AG
9.6.1 Overview
9.6.2 Financials
9.6.3 Products
9.6.4 Recent Strategic Developments
9.7 Bio-Rad Laboratories, Inc.
9.7.1 Overview
9.7.2 Financials
9.7.3 Products
9.7.4 Recent Strategic Developments
9.8 Guardant Health, Inc.
9.8.1 Overview
9.8.2 Products
9.8.3 Recent Strategic Developments
9.9 Illumina, Inc.
9.9.1 Overview
9.9.2 Financials
9.9.3 Recent Strategic Developments
9.10 Myriad Genetics, Inc.
9.10.1 Overview
9.10.2 Financials
9.10.3 Products
9.10.4 Recent Strategic Developments
9.11 Qiagen N.V.
9.11.1 Overview
9.11.2 Financials
9.11.3 Products
9.11.4 Recent Strategic Developments
10. Qualitative Analysis of the Liquid Biopsy Market
10.1 PESTEL Analysis of the Liquid Biopsy Market
10.1.1 Political
10.1.1.1 Regulatory Bodies:
10.1.1.2 Insurance / Reimbursement:
10.1.2 Economic
10.1.3 Social
10.1.4 Environmental Factors
10.1.5 Technological
10.1.5.1 Decline in use of Old Technologies and Advent of New Technologies
10.1.5.2 Early Stage Diagnosis of Cancer with Liquid Biopsies
10.1.5.3 Improved Liquid Biopsy Techniques
10.1.5.4 Comparison with Tissue Sampling
10.1.5.5 Cost Reductions and Time Saving with Liquid Biopsies
10.1.6 Legal
10.1.6.1 Regulatory Science Challenge
10.1.6.2 FDA
10.1.6.3 Lawsuits and Litigations
11. Conclusion
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Table of Tables
Table 1.1 Global Liquid Biopsy Market Forecast Segmented by Product Type Revenue ($m), AGR (%) and CAGR (%), 2017-2028
Table 2.1: Global Liquid Biopsy Market, Revenue ($m) and AGR (%) 2017-2028
Table 3.1: Global Liquid Biopsy Market, By Product Type, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 3.2: Global Liquid Biopsy Market, Instruments Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 3.3: Global Liquid Biopsy Market, Kits & Reagents Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 3.4: Global Liquid Biopsy Market, Services Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 3.5: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Product Type, 2017, 2023, 2028
Table 4.1: Global Liquid Biopsy Market, By Sample Type, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 4.2: Global Liquid Biopsy Market, Blood Sample Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 4.3: Global Liquid Biopsy Market, Urine Sample Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 4.4: Global Liquid Biopsy Market, Other Samples Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 4.5: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Sample Type, 2017, 2023, 2028
Table 5.1: Global Liquid Biopsy Market, By Biomarker Type, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 5.2: Global Liquid Biopsy Market, Circulating Tumour Cell (CTC) Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 5.3: Global Liquid Biopsy Market, Circulating Tumour DNA (ctDNA) Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 5.4: Global Liquid Biopsy Market, Exosomes Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 5.5: Global Liquid Biopsy Market, Other Biomarkers Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 5.6: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Biomarker Type, 2017, 2023, 2028
Table 6.1: Global Liquid Biopsy Market, By Cancer Type, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 6.2: Global Liquid Biopsy Market, Breast Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 6.3: Global Liquid Biopsy Market, Colorectal Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 6.4: Global Liquid Biopsy Market, Liver Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 6.5: Global Liquid Biopsy Market, Lung Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 6.6: Global Liquid Biopsy Market, Prostate Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 6.7: Global Liquid Biopsy Market, Other Cancers Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 6.8: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Cancer Type, 2017, 2023, 2028
Table 7.1: Global Liquid Biopsy Market, By End User, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 7.2: Global Liquid Biopsy Market, Hospitals Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 7.3: Global Liquid Biopsy Market, Diagnostic Laboratories Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 7.4: Global Liquid Biopsy Market, Academic Institutions Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 7.5: Global Liquid Biopsy Market, Cancer Research Centres Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 7.6: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by End User, 2017, 2023, 2028
Table 8.1: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Leading Nationals, 2017, 2023, 2028
Table 8.2: Global Liquid Biopsy Market, By Leading Nationals, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.3: North America Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.4: North America Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2017-2028
Table 8.5: US Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.6: Canada Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.7: Mexico Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.8: Europe Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.9: Europe Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2017-2028
Table 8.10: Germany Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.11: France Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.12: United Kingdom Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.13: United Kingdom Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.14: Italy Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.15: Spain Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.16: Russia Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.17: Asia-Pacific Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.18: Asia-Pacific Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2017-2028
Table 8.19: Japan Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.20: China Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.21: Australia Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.22: South Korea Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.23: India Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.24: LAMEA Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.25: LAMEA Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2017-2028
Table 8.26: Brazil Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.27: Turkey Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.28: Venezuela Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.29: Saudi Arabia Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.30: Republic of South Africa Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 9.1: Silicon Biosystems Product Portfolio
Table 9.2: Silicon Biosystems Recent Developments
Table 9.3: MDxHealth SA Financials ($m), 2015-2017
Table 9.4: MDxHealth SA Product Portfolio
Table 9.5: MDxHealth SA Recent Developments
Table 9.6: Biocept Financials ($thousand), 2014-2016
Table 9.7: Biocept Product Portfolio
Table 9.8: Biocept Recent Developments
Table 9.9: Trovagene, Inc. Financials ($thousand), 2015-2017
Table 9.10: Trovagene, Inc. Product Portfolio
Table 9.11: Trovagene, Inc. Recent Developments
Table 9.12: Sysmex Inostics Product Portfolio
Table 9.13: Sysmex Inostics Financials ($m), 2015-2017
Table 9.14: Sysmex Inostics GmbH Recent Developments
Table 9.15: Roche Financials ($m), 2015-2017
Table 9.16: Roche Product Portfolio
Table 9.17: Roche Recent Developments
Table 9.18: Bio-Rad Financials ($m), 2014-2016
Table 9.19: Bio-Rad Product Portfolio
Table 9.20: Bio-Rad Recent Developments
Table 9.21: Guardant Product Portfolio
Table 9.22: Guardant Recent Developments
Table 9.23: Illumina Financials ($m), 2014-2016
Table 9.24: Illumina (GRAIL) Recent Developments
Table 9.25: Myriad Financials ($m), 2015-2017
Table 9.26: Myriad Product Portfolio
Table 9.27: Myriad Recent Developments
Table 9.28: Qiagen Financials ($m), 2015-2017
Table 9.29: Qiagen Product Portfolio
Table 9.30: Qiagen Recent Developments
Table of Figures
Figure 2.1 Ageing Population Estimates 2010 - 2050
Figure 2.2: Global Liquid Biopsy Market Revenue ($m), 2017-2028
Figure 3.1: Global Liquid Biopsy Market Revenue ($m), By Product Type, 2017-2028
Figure 3.2: Global Liquid Biopsy Market, Instruments Segment Revenue ($m), 2017-2028
Figure 3.3: Global Liquid Biopsy Market, Kits & Reagents Segment Revenue ($m), 2017-2028
Figure 3.4: Global Liquid Biopsy Market, Services Segment Revenue ($m), 2017-2028
Figure 4.1: Global Liquid Biopsy Market Revenue ($m), By Sample Type, 2017-2028
Figure 4.2: Global Liquid Biopsy Market, Blood Sample Segment Revenue ($m), 2017-2028
Figure 4.3: Global Liquid Biopsy Market, Urine Sample Segment Revenue ($m), 2017-2028
Figure 4.4: Global Liquid Biopsy Market, Other Samples Segment Revenue ($m), 2017-2028
Figure 5.1: Global Liquid Biopsy Market Revenue ($m), By Biomarker Type, 2017-2028
Figure 5.2: Global Liquid Biopsy Market, Circulating Tumour Cell (CTC) Segment Revenue ($m), 2017-2028
Figure 5.3: Global Liquid Biopsy Market, Circulating Tumour DNA (ctDNA) Segment Revenue ($m), 2017-2028
Figure 5.4: Global Liquid Biopsy Market, Exosomes Segment Revenue ($m), 2017-2028
Figure 5.5: Global Liquid Biopsy Market, Other Biomarkers Segment Revenue ($m), 2017-2028
Figure 6.1: Global Liquid Biopsy Market Revenue ($m), By Cancer Type, 2017-2028
Figure 6.2: Global Liquid Biopsy Market, Breast Cancer Segment Revenue ($m), 2017-2028
Figure 6.3: Global Liquid Biopsy Market, Colorectal Cancer Segment Revenue ($m), 2017-2028
Figure 6.4: Global Liquid Biopsy Market, Liver Cancer Segment Revenue ($m), 2017-2028
Figure 6.5: Global Liquid Biopsy Market, Lung Cancer Segment Revenue ($m), 2017-2028
Figure 6.6: Global Liquid Biopsy Market, Prostate Cancer Segment Revenue ($m), 2017-2028
Figure 6.7: Global Liquid Biopsy Market, Other Cancers Segment Revenue ($m), 2017-2028
Figure 7.1: Global Liquid Biopsy Market Revenue ($m), By End User, 2017-2028
Figure 7.2: Global Liquid Biopsy Market, Hospitals Segment Revenue ($m), 2017-2028
Figure 7.3: Global Liquid Biopsy Market, Diagnostic Laboratories Segment Revenue ($m), 2017-2028
Figure 7.4: Global Liquid Biopsy Market, Academic Institutions Segment Revenue ($m), 2017-2028
Figure 7.5: Global Liquid Biopsy Market, Cancer Research Centres Segment Revenue ($m), 2017-2028
Figure 8.1: Global Liquid Biopsy Market Revenue ($m), By Leading Nationals, 2017-2028
Figure 8.2: North America Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.3: US Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.4: Canada Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.5: Mexico Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.6: Europe Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.7: Germany Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.8: France Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.8: United Kingdom Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.9: United Kingdom Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.10: Italy Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.11: Spain Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.12: Russia Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.13: Asia-Pacific Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.14: Japan Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.15: China Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.16: Australia Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.17: South Korea Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.18: India Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.19: LAMEA Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.20: Brazil Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.21: Turkey Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.22: Venezuela Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.23: Saudi Arabia Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.24: Republic of South Africa Liquid Biopsy Market, Revenue ($m), 2017-2028
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
